A biotechnology company building AI models for cancer therapeutics and gene therapy, from patient tumor data to designed regulatory DNA.
Origin
Released October 8, 2025
Regulatory DNA model that generates enhancer and promoter sequences and predicts their chromatin accessibility and transcription-factor binding.